Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 3 studies | 25% ± 7% |
Insufficient scRNA-seq data for expression of POMGNT2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 3458.01 | 180 / 180 | 100% | 38.20 | 428 / 430 |
| brain | 100% | 3011.72 | 2636 / 2642 | 100% | 97.49 | 703 / 705 |
| pancreas | 100% | 988.69 | 328 / 328 | 99% | 25.73 | 177 / 178 |
| breast | 100% | 1252.63 | 459 / 459 | 99% | 36.50 | 1106 / 1118 |
| thymus | 100% | 1534.74 | 653 / 653 | 99% | 33.42 | 598 / 605 |
| prostate | 100% | 1906.93 | 245 / 245 | 99% | 36.05 | 496 / 502 |
| skin | 100% | 1415.16 | 1806 / 1809 | 99% | 39.28 | 465 / 472 |
| adrenal gland | 100% | 1533.55 | 258 / 258 | 98% | 44.24 | 226 / 230 |
| uterus | 100% | 5166.55 | 170 / 170 | 98% | 39.89 | 448 / 459 |
| kidney | 100% | 1222.92 | 89 / 89 | 97% | 23.62 | 874 / 901 |
| stomach | 99% | 1358.97 | 357 / 359 | 97% | 26.88 | 278 / 286 |
| bladder | 100% | 1800.48 | 21 / 21 | 96% | 29.73 | 486 / 504 |
| lung | 99% | 1262.73 | 572 / 578 | 96% | 21.64 | 1108 / 1155 |
| intestine | 98% | 1316.55 | 948 / 966 | 95% | 23.22 | 503 / 527 |
| esophagus | 100% | 1608.04 | 1438 / 1445 | 93% | 20.86 | 170 / 183 |
| liver | 97% | 564.93 | 220 / 226 | 88% | 14.71 | 358 / 406 |
| eye | 0% | 0 | 0 / 0 | 100% | 29.66 | 80 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 24.59 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 10.49 | 1 / 1 |
| muscle | 100% | 2171.26 | 802 / 803 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1253.57 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1292.25 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 713.24 | 240 / 241 | 0% | 0 | 0 / 0 |
| heart | 98% | 1499.97 | 840 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 21% | 87.11 | 191 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 14% | 1.35 | 4 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0001764 | Biological process | neuron migration |
| GO_0006493 | Biological process | protein O-linked glycosylation |
| GO_0035269 | Biological process | protein O-linked mannosylation |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0097363 | Molecular function | protein O-acetylglucosaminyltransferase activity |
| GO_0008375 | Molecular function | acetylglucosaminyltransferase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | POMGNT2 |
| Protein name | Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (POMGnT2) (EC 2.4.1.312) (Extracellular O-linked N-acetylglucosamine transferase-like) (Glycosyltransferase-like domain-containing protein 2) |
| Synonyms | GTDC2 AGO61 EOGTL C3orf39 |
| Description | FUNCTION: O-linked mannose beta-1,4-N-acetylglucosaminyltransferase that transfers UDP-N-acetyl-D-glucosamine to the 4-position of the mannose to generate N-acetyl-D-glucosamine-beta-1,4-O-D-mannosylprotein. Involved in the biosynthesis of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1), which is required for binding laminin G-like domain-containing extracellular proteins with high affinity. . |
| Accessions | Q8NAT1 ENST00000687440.1 ENST00000689987.1 ENST00000692017.1 ENST00000693717.1 ENST00000344697.3 ENST00000686643.1 ENST00000441964.1 |